Innovative Financial Statements From 2010 to 2022

IMTH -  USA Stock  

USD 0.62  0.05  8.77%

Innovative Medtech financial statements provide useful quarterly and yearly information to potential Innovative Medtech investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Innovative Medtech financial statements helps investors assess Innovative Medtech's valuation, profitability, and current liquidity needs.
Innovative Medtech does not presently have any fundamental trends for analysis.
.

Innovative Financial Statements 

 
Refresh
Check Innovative Medtech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Innovative main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Innovative financial statements analysis is a perfect complement when working with Innovative Medtech Valuation or Volatility modules. It can also supplement various Innovative Medtech Technical models. Please see the analysis of Innovative Medtech Correlation against competitors.

Innovative Total Debt Analysis

Innovative Medtech's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Total Debt 
 = 
Bonds 
+  
Notes 
More About Total Debt | All Equity Analysis

Current Innovative Medtech Total Debt

    
  2.13 M  
Most of Innovative Medtech's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Innovative Medtech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Compare to competition

Based on the latest financial disclosure, Innovative Medtech has a Total Debt of 2.13 M. This is 99.92% lower than that of the Healthcare sector and 99.82% lower than that of the Medical Instruments & Supplies industry. The total debt for all United States stocks is 99.96% higher than that of the company.

Innovative Medtech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Innovative Medtech's current stock value. Our valuation model uses many indicators to compare Innovative Medtech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innovative Medtech competition to find correlations between indicators driving Innovative Medtech's intrinsic value. More Info.
Innovative Medtech is currently regarded as number one stock in shares owned by insiders category among related companies. It is rated fifth overall in cash and equivalents category among related companies creating about  1,258  of Cash and Equivalents per Shares Owned by Insiders. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Innovative Medtech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Innovative Medtech's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innovative Medtech's earnings, one of the primary drivers of an investment's value.

About Innovative Medtech Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Innovative Medtech income statement, its balance sheet, and the statement of cash flows. Innovative Medtech investors use historical funamental indicators, such as Innovative Medtech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Innovative Medtech investors may use each financial statement separately, they are all related. The changes in Innovative Medtech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Innovative Medtech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Innovative Medtech Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Innovative Medtech. Please read more on our technical analysis and fundamental analysis pages.
Innovative MedTech Inc., through its subsidiaries, provides health and wellness services in the United States. Innovative MedTech Inc. was incorporated in 2005 and is based in Blue Island, Illinois. Innovative Medtech operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 37 people.

Innovative Medtech Investors Sentiment

The influence of Innovative Medtech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Innovative. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Innovative Medtech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Innovative Medtech's short interest history, or implied volatility extrapolated from Innovative Medtech options trading.

Current Sentiment - IMTH

Innovative Medtech Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Innovative Medtech. What is your judgment towards investing in Innovative Medtech? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Innovative Medtech using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see the analysis of Innovative Medtech Correlation against competitors. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Innovative OTC Stock analysis

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Is Innovative Medtech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innovative Medtech. If investors know Innovative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innovative Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Innovative Medtech is measured differently than its book value, which is the value of Innovative that is recorded on the company's balance sheet. Investors also form their own opinion of Innovative Medtech's value that differs from its market value or its book value, called intrinsic value, which is Innovative Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovative Medtech's market value can be influenced by many factors that don't directly affect Innovative Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovative Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Innovative Medtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovative Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.